Due to the government shutdown, updates to information on this website may be limited or delayed. State Medicaid and Children’s Health Insurance Programs (CHIP) continue to operate. Continue to work with the programs in your state to access coverage. For more information about government operating status, visit OPM.gov.

U.S. flag

An official website of the United States government

Federal Disaster Resources

This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.

Section 1135 Waiver Flexibilities - Oregon Coronavirus Disease 2019 (Fifth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Oregon for multiple section 1135 flexibilities on March 25, 2020.  Your follow-up communication to CMS on January 12, 2021 indicated Oregon’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - New York Coronavirus Disease 2019

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New York for multiple section 1135 flexibilities on March 26, 2020.  Your Disaster Relief SPA submission, Transmittal Number 20-0048, submitted on August 25, 2020, and follow-up communication on October 7, 2020, detailed an additional federal requirement that also poses issues or challenges for the health care delivery system in New York and requested a modification of an additional requirement.

Section 1135 Waiver Flexibilities - New York Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New York for multiple section 1135 flexibilities on March 26, 2020.  Your follow-up communication to CMS on January 12, 2021, indicated New York’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Wyoming Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Wyoming for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Wyoming’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Oklahoma Coronavirus Disease 2019 (Sixth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Oklahoma for multiple section 1135 flexibilities on March 24, 2020. Your follow-up communication to CMS on January 19, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Oklahoma and requested a waiver or modification of those additional requirements.

Section 1135 Waiver Flexibilities - Nebraska Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nebraska for multiple section 1135 flexibilities on April 2, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Nebraska’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Kansas Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Kansas for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Kansas’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Colorado Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Colorado for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Colorado’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Arizona Coronavirus Disease 2019 (11th Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arizona for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communications to CMS on February 12, 2021 and March 16, 2021 indicated Arizona’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Vermont Coronavirus Disease 2019 (Fifth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Vermont for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Vermont’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show entries